Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...
(A) A comprehensive analysis of caffeine binding to one of the spike proteins; (B, C) Caffeine interacts with critical amino acids in the SARS-CoV-2 S protein’s receptor-binding domain (RBD), ...
In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...
FREMONT, Calif. & BOSTON--(BUSINESS WIRE)--Acellera Therapeutics and Psivant Therapeutics announce a strategic research collaboration to develop transformative computation approaches that will ...
Figure 1. This figure depicts the four categories of protein druggability target screening tools discussed in this section, which include structure-based methods, sequence-based methods, machine ...
The research, published in Nature Communications, aims to improve drug safety and effectiveness by accounting for genetic ...
Industry-Leading Platform Achieves 94% Accuracy with Real-Time Machine Learning, Providing Open-Access to Critical CNS Drug Development Technology Additional Predictive, Analytic and Descriptive ...
Sanford Burnham Prebys is one of several institutions contributing to the federally funded project called PREDICTS ...
This webinar series works with top educators, researchers (both academic and industrial), and government agencies in structural biology, medicinal chemistry, computational chemistry, and data science ...
Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback